RCKT
Rocket Pharmaceuticals, Inc.
$3.44
+0.03 (+0.88%)
At close · Jul 17
Market Cap
$375.63M
Shares
109,193,549
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-30 | 2026-06-24 | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-12 | 2026-06-10 | |
| 8-K | 2026-05-21 | 2026-05-20 | |
| 8-K | 2026-05-07 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-04-28 | 2026-04-26 | |
| DEF 14A | 2026-04-06 | 2026-05-20 | |
| Investor Event Transcript | 2026-03-31 | — | |
| 8-K | 2026-03-27 | 2026-03-26 | |
| 8-K | 2026-03-10 | — | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-10-14 | — | |
| 8-K | 2025-10-03 | 2025-09-29 | |
| 8-K | 2025-10-03 | — | |
| 8-K | 2025-09-29 | 2025-09-23 | |
| 8-K | 2025-09-17 | 2025-09-11 | |
| 8-K | 2025-08-25 | 2025-08-20 | |
| 8-K | 2025-08-20 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-07 | 2025-08-04 | |
| 8-K | 2025-07-24 | — | |
| 8-K | 2025-07-23 | — | |
| 8-K | 2025-07-17 | — | |
| 8-K | 2025-07-11 | 2025-07-07 | |
| 8-K | 2025-06-18 | — | |
| 8-K | 2025-05-27 | — | |
| 8-K | 2025-05-15 | — | |
| 8-K | 2025-05-08 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| DEF 14A | 2025-04-30 | 2025-06-18 | |
| 8-K | 2025-04-29 | 2025-04-26 | |
| 8-K | 2025-04-07 | — | |
| 8-K | 2025-02-27 | — | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-01-28 | 2025-01-25 | |
| 8-K | 2024-12-12 | 2024-12-09 | |
| 8-K | 2024-12-05 | 2024-12-02 | |
| 8-K | 2024-11-18 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-09-11 | 2024-09-05 | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-08-05 | — | |
| 8-K | 2024-06-28 | — | |
| 8-K | 2024-06-20 | 2024-06-13 | |
| 10-Q | 2024-05-07 | 2024-03-31 |
Showing 1–50 of 117 filings
Key facts
CIK
1281895
CUSIP
77313F106
13F (30d)
14 filings
13 filers
Visit website
Investor relations